Pure Global

Endoscopic Trigger Finger Release - Trial NCT03883477

Access comprehensive clinical trial information for NCT03883477 through Pure Global AI's free database. This phase not specified trial is sponsored by Cedars-Sinai Medical Center and is currently Enrolling by invitation. The study focuses on Trigger Finger. Target enrollment is 24 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT03883477
Enrolling by invitation
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT03883477
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Endoscopic Trigger Finger Release

Study Focus

Trigger Finger

Endoscopic Release

Interventional

device

Sponsor & Location

Cedars-Sinai Medical Center

Los Angeles, United States of America

Timeline & Enrollment

N/A

Mar 13, 2019

Dec 01, 2021

24 participants

Primary Outcome

Scar comparison between treatment arms, as measured by the Patient and Observer Scar Assessment Scale (POSAS)

Summary

The purpose of this study is to compare recovery, scar, and patient satisfaction after
 retrograde endoscopic trigger finger release versus the standard open surgical treatment.

ICD-10 Classifications

Trigger finger
Accessory finger(s)
Fused fingers
Accessory thumb(s)
Clubbing of fingers

Data Source

ClinicalTrials.gov

NCT03883477

Device Trial